Please ensure Javascript is enabled for purposes of website accessibility
DaVita Stock Quote

DaVita (NYSE: DVA)

$79.38
(1.2%)
$0.91
Price as of March 30, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

DaVita Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
DVA -32.11% +19.00% +3.54% +1,826%
S&P -13.04% +52.52% +8.80% +593%

DaVita Company Info

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

News & Analysis

The Fool has written over 100 articles on DaVita.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
402%
 
S&P 500 Returns
117%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/30/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.